WPC
REGN icon

Wedmont Private Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Wedmont Private Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$871K Buy
1,310
+112
+9% +$76.2K 0.02% 382
2026
Q1 		$929K Buy
1,198
+76
+7% +$58.2K 0.03% 340
2025
Q4 		$911K Sell
1,122
-21
-2% -$14.3K 0.03% 313
2025
Q3 		$667K Buy
1,143
+436
+62% +$247K 0.02% 369
2025
Q2 		$391K Sell
707
-66
-9% -$36.8K 0.02% 494
2025
Q1 		$428K Sell
773
-934
-55% -$642K 0.02% 423
2024
Q4 		$1.19M Buy
1,707
+211
+14% +$177K 0.06% 189
2024
Q3 		$1.49M Buy
1,496
+65
+5% +$72.3K 0.09% 143
2024
Q2 		$1.57M Buy
1,431
+8
+0.6% +$7.75K 0.1% 123
2024
Q1 		$1.34M Buy
1,423
+233
+20% +$222K 0.1% 137
2023
Q4 		$1.07M Buy
1,190
+141
+13% +$116K 0.09% 148
2023
Q3 		$873K Buy
1,049
+172
+20% +$135K 0.09% 150
2023
Q2 		$630K Sell
877
-124
-12% -$95.6K 0.07% 199
2023
Q1 		$825K Buy
1,001
+214
+27% +$161K 0.11% 135
2022
Q4 		$580K Buy
787
+65
+9% +$48K 0.09% 178
2022
Q3 		$497K Buy
722
+187
+35% +$118K 0.1% 164
2022
Q2 		$316K Buy
535
+38
+8% +$24.7K 0.07% 224
2022
Q1 		$347K Buy
497
+149
+43% +$94.3K 0.08% 206
2021
Q4 		$214K Buy
+348
New +$214K 0.07% 223

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Wedmont Private Capital's REGN Position: Q2 2026 in Review

Wedmont Private Capital increased its Regeneron Pharmaceuticals (REGN) stake by 9.3% in Q2 2026, buying an estimated $76.2K and bringing the position to 1,310 shares worth $871K. The position accounts for 0.02% of the portfolio, ranked #382.

Wedmont Private Capital first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.57M in Q2 2024. 335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Wedmont Private Capital held 1,310 shares of Regeneron Pharmaceuticals worth $871K as of Q2 2026.
  • Wedmont Private Capital bought 112 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
  • Regeneron Pharmaceuticals made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #382 holding.
  • Wedmont Private Capital first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Wedmont Private Capital's Regeneron Pharmaceuticals position peaked at $1.57M in Q2 2024.
  • 335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.